FOLR1 and adenoma: Since OTL38 is folate receptor-alpha targeted (which is mainly expressed in non-functioning adenomas), the sensitivity and specificity was calculated only in non-functioning adenomas with (n = 28) and without (n = 18) overexpression of FRα.